Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly in the development of targeted cancer therapies. Its structure allows for selective binding to specific enzyme active sites, making it valuable in optimizing drug potency and selectivity. Also employed in the preparation of bioactive molecules for neurological disorder studies due to its ability to cross the blood-brain barrier. Commonly utilized in structure-activity relationship (SAR) studies to enhance metabolic stability and improve pharmacokinetic profiles of lead compounds.